- Home
- BHRB vs CRMD Comparison
BHRB vs CRMD Comparison
Compare BHRB & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHRB
- CRMD
- Stock Information
- Founded
- BHRB 1852
- CRMD 2006
- Country
- BHRB United States
- CRMD United States
- Employees
- BHRB N/A
- CRMD N/A
- Industry
- BHRB Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- BHRB Finance
- CRMD Health Care
- Exchange
- BHRB Nasdaq
- CRMD Nasdaq
- Market Cap
- BHRB 907.7M
- CRMD 876.7M
- IPO Year
- BHRB N/A
- CRMD 2010
- Fundamental
- Price
- BHRB $61.00
- CRMD $11.27
- Analyst Decision
- BHRB Strong Buy
- CRMD Strong Buy
- Analyst Count
- BHRB 3
- CRMD 7
- Target Price
- BHRB $71.67
- CRMD $17.43
- AVG Volume (30 Days)
- BHRB 45.4K
- CRMD 3.2M
- Earning Date
- BHRB 10-23-2025
- CRMD 11-12-2025
- Dividend Yield
- BHRB 3.57%
- CRMD N/A
- EPS Growth
- BHRB 264.64
- CRMD N/A
- EPS
- BHRB 7.05
- CRMD 2.25
- Revenue
- BHRB $331,643,000.00
- CRMD $214,303,672.00
- Revenue This Year
- BHRB $51.05
- CRMD $565.64
- Revenue Next Year
- BHRB $5.90
- CRMD $46.09
- P/E Ratio
- BHRB $8.73
- CRMD $4.99
- Revenue Growth
- BHRB 82.85
- CRMD 1647.67
- 52 Week Low
- BHRB $47.57
- CRMD $5.60
- 52 Week High
- BHRB $72.68
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- BHRB 52.69
- CRMD 50.10
- Support Level
- BHRB $59.80
- CRMD $10.75
- Resistance Level
- BHRB $63.12
- CRMD $12.89
- Average True Range (ATR)
- BHRB 1.45
- CRMD 0.73
- MACD
- BHRB 0.24
- CRMD 0.03
- Stochastic Oscillator
- BHRB 64.58
- CRMD 31.01
About BHRB Burke & Herbert Financial Services Corp.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.